Table 5.
Functional Groups | All Drugs | Oral Drug | CNS Drugs | Cardiovascular Drugs | Anti-Infective Drugs | Anti-Cancer Drugs | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 a | 2 a | >2 a | 1 a | 2 a | >2 a | 1 a | 2 a | >2 a | 1 a | 2 a | >2 a | 1 a | 2 a | >2 a | 1 a | 2 a | >2 a | |
-F | 5.4 | 1.6 | 0.4 | 6.8 | 2.1 | 0.4 | 9.2 | 2.0 | 0 | 2.9 | 1.2 | 0.2 | 6.4 | 2.0 | 1.2 | 6.6 | 1.6 | 0.2 |
-CF3 | 2.5 | 0.2 | 0.1 | 2.8 | 0.4 | 0 | 3.9 | 0.4 | 0.1 | 2.3 | 0.1 | 0.2 | 0.9 | 0.1 | 0 | 1.8 | 0 | 0 |
-CN | 2.4 | 0.2 | 0 | 2.1 | 0.5 | 0 | 2.0 | 0 | 0 | 3.8 | 0.3 | 0 | 2.0 | 0.3 | 0 | 1.1 | 0.5 | 0 |
-NO2 | 2.0 | 0.1 | 0 | 3.3 | 0.1 | 0 | 1.5 | 0 | 0 | 2.5 | 0 | 0 | 5.1 | 0.8 | 0 | 2.0 | 0.5 | 0 |
-NH2 | 9.3 | 1.1 | 0.5 | 11.1 | 1.2 | 0 | 6.8 | 0.5 | 0 | 7.1 | 0.3 | 0 | 23.2 | 2.7 | 2.5 | 17.6 | 3.2 | 0.5 |
-OH | 20.0 | 7.2 | 6.1 | 19.1 | 6.2 | 6.5 | 14.0 | 2.9 | 1.2 | 24.1 | 6.2 | 4.8 | 19.0 | 7.2 | 13.3 | 14.3 | 11.3 | 15.8 |
-SH | 0.3 | 0 | 0 | 0.5 | 0.1 | 0 | 0.1 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 | 0 |
-CHO | 0.7 | 0 | 0 | 0.7 | 0 | 0 | 0.2 | 0 | 0 | 0.4 | 0 | 0.1 | 1.9 | 0 | 0 | 0.7 | 0 | 0 |
-COOH | 12.9 | 1.7 | 0.3 | 16.8 | 1.0 | 0.1 | 3.6 | 0.6 | 0.2 | 12.3 | 2.2 | 0 | 26.9 | 2.5 | 0.1 | 7.7 | 2.7 | 0.9 |
-CONHOH | 0.2 | 0 | 0 | 0.4 | 0 | 0 | 0.1 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0.1 | 0 | 1.1 | 0 | 0 |
-COOR | 16.1 | 3.6 | 1.0 | 14.1 | 4.5 | 0.8 | 9.4 | 1.3 | 0.2 | 14.7 | 7.6 | 2.0 | 13.6 | 3.5 | 1.3 | 13.1 | 3.8 | 4.8 |
-CONH2 | 3.5 | 0.1 | 0.1 | 4.5 | 0.1 | 0 | 5.5 | 0.4 | 0 | 3.0 | 0.2 | 0 | 5.2 | 0 | 0 | 3.4 | 0 | 0 |
-SO3H | 0.7 | 0.2 | 0 | 0.3 | 0.2 | 0 | 0.2 | 0.3 | 0 | 0.3 | 0 | 0 | 1.2 | 0.3 | 0.1 | 0.2 | 0 | 0 |
-SO2NH2 | 1.3 | 0.1 | 0 | 2.6 | 0.1 | 0 | 0.7 | 0 | 0 | 0.7 | 0 | 0 | 0.9 | 0.1 | 0 | 0.7 | 0 | 0 |
a “1, 2, 3, > 3” in row represent the number of functional groups.